COMMITMENTS AND CONTINGENCIES |
12 Months Ended |
---|---|
Dec. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 4 – COMMITMENTS AND CONTINGENCIES
In prior years, the Company entered into consulting agreements with one director, three executive officers, and one engineer of the Company, which included commitments to issue shares of the Company’s common stock from the Company’s 2017 Stock Incentive Plan and 2019 Stock Incentive Plans. The authorized shares pursuant to the 2017 Stock Incentive Plan were shares, and per 2019 Stock Incentive Plan were shares. All the consulting agreements have been terminated, and shares have been issued in conjunction with the related separation agreements. According to the terms of the agreements, shares were vested and issued per the Company’s 2017 Stock Incentive Plan as of December 31, 2024 and 2023, and shares were vested and issued per the Company’s 2019 Stock Incentive Plan as of December 31, 2024 and 2023, respectively.
In the event that the agreement is terminated by either party pursuant to the terms of the agreement, all unvested shares which have been earned shall vest on a pro-rata basis as of the effective date of the termination of the agreement and all unearned, unvested shares shall be terminated. The value of the shares was assigned at fair market value on the effective date of the agreement and the pro-rata number of shares earned was calculated and amortized at the end of each reporting period.
On March 18, 2022, the Company adopted 2022 Stock Incentive Plan and reserved shares of common stock for incentivizing its management team. Pursuant to the terms of the 2022 Plan, shares of common stock were vested, and shares were issued as of December 31, 2024 and 2023, respectively.
Employment Agreement – CEO
On June 2, 2022, the Board approved an Employment Agreement with the CEO dated effective April 1, 2022 whereby, the CEO will receive an annual salary of $100,000 which accrues unless converted into shares of common stock of the Company at a stipulated conversion rate. If the Company reaches $1,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $150,000 commencing the following month. If the Company reaches $5,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $200,000 commencing the following month. The Company awarded the CEO an aggregate of 279,352 and $199,053 in salaries payable to the CEO as of December 31, 2024 and 2023, respectively. shares of the Company’s common stock under the 2022 Stock Incentive Plan, which will vest (i) shares on April 1, 2023, (ii) shares on April 1, 2024, and (iii) shares on April 1, 2025. The shares are valued at 90% of the average market price of the shares of 30 trading days at the end of each quarter. The Company has recorded $
Employment Agreement – COO/Interim CFO
On June 2, 2022, the Board approved an Employment Agreement with the COO/Interim CFO dated effective April 1, 2022, whereby, the officer will receive an annual salary of $100,000 which accrues unless converted into shares of common stock of the Company at a stipulated conversion rate. If the Company reaches $1,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $150,000 commencing the following month. If the Company reaches $5,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $200,000 commencing the following month. The Company awarded the COO/Interim CFO an aggregate of 263,041 and $181,526 in salaries payable to the COO/Interim CFO as of December 31, 2024 and 2023, respectively. shares of the Company common stock under the 2022 Stock Incentive Plan, which will vest (i) shares on April 1, 2023, (ii) shares on April 1, 2024, and (iii) shares on April 1, 2025. The shares are valued at 90% of the average market price of the shares of 30 trading days at the end of each quarter. The Company recorded $
|